Optimisation of fermentation conditions for the production of a novel GABA-benzodiazepine receptor agonist by Acremonium strictum

Journal of Industrial Microbiology

Volumn 17, Issue 1, 1996, Pages 36-40

  Blackburn, M ^a   Fauth, U ^a   Katzer, W ^a   Renno, D ^a   Trew, S ^a  

^a Cantab Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Fermentation optimisation; Sesquiterpene polyketide; XR368

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG; XR 368;

ACREMONIUM; ARTICLE; BIOMASS; CONTROLLED STUDY; FERMENTATION; NONHUMAN;

ACREMONIUM STRICTUM;

EID: 0029782405     PISSN: 01694146     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01570146     Document Type: Article

References (7)

1. Ainsworth AM, MI Chicarelli-Robinson, BR Copp, U Fauth, PJ Hylands, JA Holloway, M Latif, GB O'Beirne, N Porter, DV Renno, M Richards and N Robinson. 1995. Xenovulene A, a novel GABA-benzodiazepine receptor binding compound produced by Acremonium strictum. J Antibiot 48: 568-573.
2. Bartoshevich YE, PL Zaslavskaya, MJ Novak and OD Yundina. 1990. Acremonium chrysogenum differentiation and biosynthesis of cephalosporin. J Basic Microbiol 30: 313-320.
3. Felix H. 1982. Permeabilised cells. Anal Biochem 120: 211-234.
4. Monaghan RL and LR Koupal. 1989. Use of the Plackett-Burman technique in a discovery program for new natural products. In: Novel Microbial Products for Medicine and Agriculture (Demain AL, GA Somkuti, JC Hunter-Cervera and HW Rossmore, eds), pp 25-32, Elsevier, Amsterdam and New York.
5. Plackett RL and JP Burman. 1949. The design of optimum multifactorial experiments. Biometrika 33: 305-325.
6. Renno DV, GB O'Beirne and BR Copp (Xenova Ltd). 1994. International Patent Application WO 94/14814/
7. Warr SRC, SJ Box, C Burbidge, H Edwards and JJ Jones. 1994. Milbemycin production by Streptomyces sp: the effect of carbohydrates. J Ind Microbiol 13: 43-48.